SCHEMBL28102741

SCHEMBL28102741

CCC(=O)ONC(=O)c1ccccc1N

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.51
HSD17B10 Q99714 7/20 0.51
CFTR P13569 1/20 0.51
KDM4E B2RXH2 11/20 0.50
HPGD P15428 7/20 0.50
RCE1 Q9Y256 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.46
USP2 O75604 1/20 0.45
POLB P06746 1/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
FADS1 O60427 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27484400 0.80 TRIM24 (0.38) ALDH1A1HSD17B10KDM4EHPGDSMN1; SMN2
SCHEMBL1558090 0.79 ALDH1A1 (0.59) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL4315070 0.77 ALDH1A1 (0.61) ALDH1A1HSD17B10SMN1; SMN2MAPK1POLB
SCHEMBL1534012 0.77 ALDH1A1 (0.66) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL692347 0.77 ALDH1A1 (0.66) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL28221971 0.76 CES2 (0.47) ALDH1A1KDM4EHPGDSMN1; SMN2TP53
SCHEMBL27584095 0.76 HTT (0.59) ALDH1A1KDM4EHPGDSMN1; SMN2POLB
SCHEMBL1202541 0.75 ALDH1A1 (0.64) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL8745364 0.74 ALDH1A1 (0.60) ALDH1A1HSD17B10CFTRKDM4EHPGD
SCHEMBL28828371 0.74 MEN1 (0.47) ALDH1A1HSD17B10KDM4ESMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101400699-A Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions BRISTOL MYERS SQUIBB CO (US) 2009-04-01 CN claimed
CN-102844327-B Template-fixed peptidomimetics with CXCR7 modulatory activity 波利弗尔股份公司 2016-10-26 CN disclosed